(R)-9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine is a potent inhibitor of feline immunodeficiency virus infection. 1995

T W Vahlenkamp, and A De Ronde, and J Balzarini, and L Naesens, and E De Clercq, and M J van Eijk, and M C Horzinek, and H F Egberink
Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, The Netherlands.

The antiviral efficacy of acyclic nucleoside phosphonates, including 9-(2-phosphonylmethoxyethyl)adenine (PMEA) and (R)-9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine [(R)-PMPDAP] against feline immunodeficiency virus (FIV) infection was determined. (R)-PMPDAP showed the highest selectivity index (> 2,000) in vitro. Treatment of experimentally FIV-infected asymptomatic cats with PMEA or (R)-PMPDAP had no effect on the CD4+/CD8+ ratio. However, mean plasma viral RNA concentrations decreased significantly in the (R)-PMPDAP-treated cats. Our data show that, in comparison to PMEA, (R)-PMPDAP is a more potent and less toxic inhibitor of FIV replication both in vitro and in vivo.

UI MeSH Term Description Entries
D009943 Organophosphorus Compounds Organic compounds that contain phosphorus as an integral part of the molecule. Included under this heading is broad array of synthetic compounds that are used as PESTICIDES and DRUGS. Organophosphorus Compound,Organopyrophosphorus Compound,Organopyrophosphorus Compounds,Compound, Organophosphorus,Compound, Organopyrophosphorus,Compounds, Organophosphorus,Compounds, Organopyrophosphorus
D002415 Cats The domestic cat, Felis catus, of the carnivore family FELIDAE, comprising over 30 different breeds. The domestic cat is descended primarily from the wild cat of Africa and extreme southwestern Asia. Though probably present in towns in Palestine as long ago as 7000 years, actual domestication occurred in Egypt about 4000 years ago. (From Walker's Mammals of the World, 6th ed, p801) Felis catus,Felis domesticus,Domestic Cats,Felis domestica,Felis sylvestris catus,Cat,Cat, Domestic,Cats, Domestic,Domestic Cat
D000225 Adenine A purine base and a fundamental unit of ADENINE NUCLEOTIDES. Vitamin B 4,4, Vitamin B,B 4, Vitamin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D016089 Immunodeficiency Virus, Feline A species of LENTIVIRUS, subgenus feline lentiviruses (LENTIVIRUSES, FELINE) isolated from cats with a chronic wasting syndrome, presumed to be immune deficiency. There are 3 strains: Petaluma (FIP-P), Oma (FIP-O) and Puma lentivirus (PLV). There is no antigenic relationship between FIV and HIV, nor does FIV grow in human T-cells. FIV,FTLV,Feline Immunodeficiency Virus,Feline T-Lymphotropic Lentivirus,Lentivirus, Puma,Puma lentivirus,Feline T-Lymphotropic Virus,Feline Immunodeficiency Viruses,Feline T Lymphotropic Lentivirus,Feline T Lymphotropic Virus,Lentivirus, Feline T-Lymphotropic,T-Lymphotropic Lentivirus, Feline,T-Lymphotropic Virus, Feline
D016181 Feline Acquired Immunodeficiency Syndrome Acquired defect of cellular immunity that occurs in cats infected with feline immunodeficiency virus (FIV) and in some cats infected with feline leukemia virus (FeLV). AIDS, Feline,FAIDS,Feline AIDS,Feline Acquired Immune Deficiency Syndrome,Feline Acquired Immuno-Deficiency Syndrome,Feline Acquired Immuno Deficiency Syndrome

Related Publications

T W Vahlenkamp, and A De Ronde, and J Balzarini, and L Naesens, and E De Clercq, and M J van Eijk, and M C Horzinek, and H F Egberink
February 2015, Journal of feline medicine and surgery,
T W Vahlenkamp, and A De Ronde, and J Balzarini, and L Naesens, and E De Clercq, and M J van Eijk, and M C Horzinek, and H F Egberink
January 2012, Journal of veterinary internal medicine,
T W Vahlenkamp, and A De Ronde, and J Balzarini, and L Naesens, and E De Clercq, and M J van Eijk, and M C Horzinek, and H F Egberink
February 1996, Biochemical and biophysical research communications,
T W Vahlenkamp, and A De Ronde, and J Balzarini, and L Naesens, and E De Clercq, and M J van Eijk, and M C Horzinek, and H F Egberink
February 2012, Journal of feline medicine and surgery,
T W Vahlenkamp, and A De Ronde, and J Balzarini, and L Naesens, and E De Clercq, and M J van Eijk, and M C Horzinek, and H F Egberink
March 1988, Molecular pharmacology,
T W Vahlenkamp, and A De Ronde, and J Balzarini, and L Naesens, and E De Clercq, and M J van Eijk, and M C Horzinek, and H F Egberink
January 2024, Photochemistry and photobiology,
T W Vahlenkamp, and A De Ronde, and J Balzarini, and L Naesens, and E De Clercq, and M J van Eijk, and M C Horzinek, and H F Egberink
November 1995, Science (New York, N.Y.),
T W Vahlenkamp, and A De Ronde, and J Balzarini, and L Naesens, and E De Clercq, and M J van Eijk, and M C Horzinek, and H F Egberink
December 1989, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
T W Vahlenkamp, and A De Ronde, and J Balzarini, and L Naesens, and E De Clercq, and M J van Eijk, and M C Horzinek, and H F Egberink
February 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association,
T W Vahlenkamp, and A De Ronde, and J Balzarini, and L Naesens, and E De Clercq, and M J van Eijk, and M C Horzinek, and H F Egberink
October 2006, Virology,
Copied contents to your clipboard!